Abstract
Recently, NLR has been attracting attention as a prognostic factor for various cancers. However, its usefulness has not been well reviewed about advanced SCLC. Furthermore, its examination of NLR has been limited to first-line chemotherapy. Therefore, we retrospectively examined not only NLR at the start of first-line chemotherapy but its dynamic change during treatment.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call